Health · 1 view
Enhanced CAR T-cell therapy shows early promise for B-cell cancers in first-in-human trial
Results from a Phase I clinical trial led by The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J.
Summary
Results from a Phase I clinical trial led by The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC—James) show a possible way to improve therapy options for patients with relapsed or treatment-resistant B-cell blood cancers. The findings are published in Blood Cancer Discovery .
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedCoverage Context
More from Health
Continue reading recent Health coverage
- Smoking may affect fertility in both men and womenContinue reading
- People report greater willingness to risk infection with those they valueContinue reading
- Cardiac Microcurrent Therapy Raises Eyebrows in Heart FailureContinue reading
- Scientists identify clues to making immunotherapy more effective against glioblastomaContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow